Protocol shift from agonist to antagonist or vice versa after an unsuccessful intracytoplasmic sperm injection cycle on the same patient does not improve outcome


ŞÜKÜR Y. E., Ulusoy C. O., ÖZMEN B., SÖNMEZER M., BERKER B., Aytac R., ...Daha Fazla

TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, cilt.57, sa.3, ss.417-420, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 57 Sayı: 3
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.tjog.2018.04.016
  • Dergi Adı: TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.417-420
  • Anahtar Kelimeler: GnRH agonist, GnRH antagonist, Pregnancy rate, Protocol shift, Same patient, GNRH ANTAGONIST, OVARIAN STIMULATION, HORMONE, CETRORELIX, SINGLE, IVF
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: While there's a growing data on the comparison of GnRH agonist and GnRH antagonist protocols, no clear study exists on the effects of both protocols on the same patient. The aim of the present study was to compare the success rates of protocol shift and proceeding with the same protocol after an unsuccessful intracytoplasmic sperm injection (ICSI) cycle.